Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.
Cardiovascular diabetology ·2016 ·38 citas
Josefa Girona, Daiana Ibarretxe, Nuria Plana, Sandra Guaita-Esteruelas, Núria Amigó, Mercedes Heras, Luis Masana
- Tipo de publicación
- Artículo original
- Citas
- 38 (OpenAlex, 16 de octubre de 2026)
- PMID
- 27488210
Ámbito de estudio
- Enfermedad cardiovascular y lípidos
Plataforma analítica
- Perfil de lipoproteínas por RMN
Matriz
- Suero o plasma
Relacionado
Biomarcadores
Publicaciones con los mismos biomarcadores
- Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. 2015 · Journal of lipid research · 198 citas
- HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk. 2019 · International journal of molecular sciences · 107 citas
- An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. 2019 · Expert opinion on therapeutic targets · 53 citas
Ver 14 más Ver menos
- Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders. 2016 · Clinica e investigacion en arteriosclerosis · 45 citas
- Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia. 2022 · Circulation · 25 citas
- Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children. 2018 · Journal of clinical lipidology · 24 citas
- Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients. 2015 · Atherosclerosis · 23 citas
- Improvement of the omega 3 index of healthy subjects does not alter the effects of dietary saturated fats or n-6PUFA on LDL profiles. 2017 · Metabolism: clinical and experimental · 19 citas
- Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. 2017 · European journal of clinical nutrition · 18 citas
- Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia. 2018 · Atherosclerosis · 14 citas
- PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. 2023 · International journal of molecular sciences · 13 citas
- Precipitated sdLDL: An easy method to estimate LDL particle size. 2020 · Journal of clinical laboratory analysis · 12 citas
- Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study. 2021 · Journal of clinical medicine · 11 citas
- Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. 2024 · European journal of clinical investigation · 7 citas
- Chronic kidney disease induces a distinct lipidomic signature and accelerates atherosclerosis progression in a novel minipig model. 2026 · Laboratory animal research · 1 cita
- Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity. 2026 · Clinica e investigacion en arteriosclerosis
- A case of hypocholesterolemia under study. 2023 · Clinica e investigacion en arteriosclerosis